Clinical Trials Logo

Clinical Trial Summary

Eating Disorders (ED) are a major public health problem. Current care remains only partially effective and the pathophysiology of the disorders remains to be deepened. With regard to compulsive ED (bulimia and binge eating disorder), our clinical experience suggests that one of the major triggers for crisis may be related to glycemia. In fact, bulimia could be considered as a vicious circle where the binge eating disorder is going to be followed by a food restriction in order to control weight , putting the subject in a situation of "energy deficiency" which will favor the emergence of new crises . Technological advances have resulted in the emergence of new measuring devices, such as "tracking", which records continuous glycemia, which would allow us to explore these clinical hypotheses.


Clinical Trial Description

This is an open-label, exploratory, proof-of-concept study. 20 patients will be recruited from the day hospital of the Endocrinology and Nutrition Department of the University Hospital of Montpellier, Lapeyronie and from Emergencies and Post-psychiatric Emergencies Department. During the inclusion visit, the dietician will explain to the patient the use of the dietary book and the glycemic sensor which will be allocated to it. The patient will also answer to self-questionnaires about his eating behavior. No nutritional approach will be addressed so as not to alter the patient's eating behavior and not to influence the results. They will be followed-up during 14 days. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04211818
Study type Interventional
Source University Hospital, Montpellier
Contact Sébastien GUILLAUME
Phone +33(0)467338289
Email s-guillaume@chu-montpellier.fr
Status Recruiting
Phase N/A
Start date October 16, 2020
Completion date July 2023

See also
  Status Clinical Trial Phase
Recruiting NCT04038190 - A Behavioral Activation Intervention Administered in a College Freshman Orientation Course Phase 2
Terminated NCT04278755 - Binge Eating & Birth Control Phase 2
Completed NCT00537810 - Treatment of Binge Eating in Obese Patients in Primary Care Phase 4
Recruiting NCT05509257 - Naltrexone Neuroimaging in Teens With Eating Disorders Early Phase 1
Completed NCT03687658 - Applying Novel Technologies and Methods to Self-Regulation: Behavior Change Tools for Smoking and Binge Eating N/A
Recruiting NCT05937243 - Identifying Effective Technological-based Augmentations to Enhance Outcomes From Self-help Cognitive Behavior Therapy for Binge Eating N/A
Completed NCT00607789 - Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression Phase 4
Completed NCT04117542 - Working Memory in Overweight Children With and Without Loss of Control Eating
Completed NCT03429114 - Emotion Regulation in Binge Eating and Purging Among Adolescents
Completed NCT05041660 - Using Virtual Reality and Sensor Technology to Enhance Outcomes From Treatment for Binge Eating N/A
Completed NCT03007459 - The Health of Competitive Fitness Athletes
Completed NCT02180984 - The Effects of Repetitive Transcranial Magnetic Stimulation in Obese People With BED N/A
Completed NCT00829283 - Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care N/A
Completed NCT00307619 - An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder. Phase 3
Active, not recruiting NCT04127214 - The ITA Model of Integrated Treatment of Eating Disorders
Not yet recruiting NCT06129461 - A Single Session Self-guided Acceptance-based Digital Intervention Targeting Food Cravings in Pregnancy N/A
Recruiting NCT05177705 - The Intersection Between Loss of Control Eating and Obesity: The Role of Restriction and Food Reinforcement Early Phase 1
Recruiting NCT02716831 - Improving Treatments for Bulimia Nervosa: Innovation in Psychological Interventions for Regulating Eating N/A
Completed NCT03850288 - Inhibitory Control and Eating Disorders
Completed NCT00680979 - Preventing Excessive Weight Gain in Adolescent Girls at High-Risk for Adult Obesity Phase 2